Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Aug 6, 2024; 12(22): 4940-4946
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.4940
Table 1 Baseline characteristics of the studied population, n (%)
      
Severe MPP (n = 80)
Mild MPP (n = 80)
P value
Sex (male, %)38 (47.5)43 (53.8)0.362
Age, yr6.82 ± 2.557.63 ± 2.670.287
Asthma20 (25)4 (5)0.001
Allergic rhinitis36 (45)32 (40)0.325
Fever time, d6.54 ± 2.833.65 ± 1.810.001
Hospital stay, d9.25 ± 2.536.54 ± 2.580.001
Oxygen need 80 (100)5 (6.25)0.001
PICU stay, d3.62 ± 1.5300.001
PIBO18 (22.5)00.001
Pleural effusion 16 (20)00.001
Macrolide-resistant MPP74 (92.5)32 (40)0.001
Extrapulmonary manifestations 48 (60)2 (2.5)0.001
Lung consolidation58 (72.5)4 (5)0.001
Table 2 Inflammatory cytokines and laboratory findings between severe mycoplasma pneumoniae pneumonia group and mild group
      
Severe MPP (n = 80)
Mild MPP (n = 80)
P value
WBC (109/L)8.5 ± 1.27.6 ± 1.40.386
CRP (mg/L)21.4 ± 5.85.4 ± 2.60.001
PCT (ng/mL)0.25 ± 0.120.05 ± 0.010.001
ESR (mm/h)32.6 ± 7.915.8 ± 4.60.001
Albumin (g/L)39.4 ± 4.240.5 ± 3.80.412
LDH (U/L)484.2 ± 61.4246.9 ± 54.60.001
D-dimer (mg/L)1.2 ± 0.60.35 ± 0.140.001
IL-6 (pg/mL)25.7 ± 5.610.6 ± 3.80.001
IL-8 (pg/mL)102.4 ± 38.828.6 ± 14.30.001
IL-10 (pg/mL)36.6 ± 8.98.4 ± 2.60.001
TNF-α (pg/mL)26.6 ± 6.512.2 ± 4.40.001
Table 3 Logistic regression analysis predictors of severe Mycoplasma pneumoniae pneumonia
Factors
OR
95%CI
P value
CRP3.241.36-6.380.267
PCT1.61.41-3.810.564
ESR2.451.36-4.640.642
LDH2.831.58-5.900.001
IL-64.823.26-8.920.001
IL-85.234.42-7.850.415
IL-108.966.28-12.560.001
TNF-α5.854.23-7.940.001
D-dimer1.881.28-2.580.001
Lung consolidation9.246.56-12.480.001
Extrapulmonary manifestations7.245.12-10.260.001
Pleural effusion4.423.15-6.220.524
Macrolide-resistant MPP8.276.82-16.740.001
Asthma4.273.56-9.560.001